Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pediatric surgery international (Print)

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00383-004-1329-xPMID 15619091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenesis and outcome of biliary atresia: current concepts.

  2003cited by this paper
• Genetic induction of proinflammatory immunity in children with biliary atresia.

  2002cited by this paper
• Mechanisms of hepatotoxicity.

  2002cited by this paper
• Biliary atresia at the dawn of a new century.

  2001cited by this paper
• Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents

  2001cited by this paper
• Serum IFN-inducible protein-10: a new clinical prognostic predictor of hepatocyte death in biliary atresia.

  1999cited by this paper
• Value of gamma-glutamyl transpeptidase for early diagnosis of biliary atresia.

  1998cited by this paper
• Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis.

  1998cited by this paper
• Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia.

  1998cited by this paper
• Interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis or idiopathic pulmonary fibrosis.

  1997cited by this paper
• Long-term results with the Kasai operation for biliary atresia.

  1996cited by this paper
• Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival.

  1996cited by this paper
• Biliary atresia: Current concepts and research directions. Summary of a symposium

  1996cited by this paper
• Interleukin-8 and granulocyte-macrophage colony-stimulating factor secretion in hepatocellular carcinoma and viral chronic active hepatitis.

  1995cited by this paper
• Calculation of biliary atresia prognostic index using a multivariate linear model.

  1995cited by this paper
• Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

  1994cited by this paper
• Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups.

  1993cited by this paper
• Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease.

  1993cited by this paper
• Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma.

  1992cited by this paper
• Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system.

  1992cited by this paper
• Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.

  1992cited by this paper
• Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration.

  1992cited by this paper
• Serum levels of cytokines in chronic liver diseases.

  1992cited by this paper
• Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.

  1992cited by this paper
• Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells

  1990cited by this paper
• Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes.

  1990cited by this paper
• The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate

  1989cited by this paper
• Efficacy and safety of constant-rate intravenous cyclosporine infusion immediately after heart transplantation.

  1989cited by this paper
• Extrahepatic Biliary Atresia

  1984cited by this paper
• Summary of a Symposium

  1961cited by this paper

• The immunological profile of children with portal hypertension.

  2025cites this paper
• Elevated serum IL-34 is correlated with disease severity in patients with biliary atresia following Kasai portoenterostomy.

  2023cites this paper
• Diagnostic values of plasma matrix metalloproteinase-7, interleukin-8, and gamma-glutamyl transferase in biliary atresia

  2022cites this paper
• Prognostic and Pathophysiologic Significance of IL-8 (CXCL8) in Biliary Atresia

  2021cites this paper
• CXCL8high inflammatory B cells in the peripheral blood of patients with biliary atresia are involved in disease progression

  2020cites this paper
• Predicting native liver injury and survival in biliary atresia.

  2020cites this paper
• Systems Analysis of Biliary Atresia Through Integration of High-Throughput Biological Data

  2020cites this paper
• Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy

  2019cites this paper
• Long‐term outcome and necessity of liver transplantation in infants with biliary atresia are independent of cytokine milieu in native liver and serum

  2018cites this paper
• Liver, Pancreas and Biliary Tract MicroRNA-499 Rs3746444 polymorphism and biliary atresia

  2016cites this paper
• Early type I collagen deposition is associated with prognosis in biliary atresia.

  2016cites this paper
• Significant hepatic expression of IL-2 and IL-8 in biliary atresia compared with other neonatal cholestatic disorders.

  2016cites this paper
• MicroRNA-499 Rs3746444 polymorphism and biliary atresia.

  2016cites this paper
• Brain-Derived Neurotrophic Factor in Children and Adolescents with Cirrhosis Due to Biliary Atresia

  2016cites this paper
• Interleukin‐8: A critical chemokine in biliary atresia

  2015cites this paper
• Cardiopulmonary hemodynamics for accurate diagnosis of portopulmonary hypertension: A redefinition to consider

  2015cites this paper
• System ( tm ) for Cytokine

  2015cites this paper
• Hepatic expression of interleukin 8 in diagnosing biliary atresia

  2015cites this paper
• Reply: To PMID 24493287.

  2015cites this paper
• Gene expression signature for biliary atresia and a role for interleukin‐8 in pathogenesis of experimental disease

  2014cites this paper
• Soluble receptor for advanced glycation end products and liver stiffness in postoperative biliary atresia.

  2013cites this paper
• Elevated Serum IL-18 and Interferon-Gamma in Medium-Term Survivors of Biliary Atresia

  2012cites this paper
• Cytokines in human milk and late‐onset breast milk jaundice

  2012cites this paper
• Interleukin 1beta level in human colostrum in relation to neonatal hyperbilirubinemia.

  2012cites this paper
• Biliary atresia and inflammation: from pathogenesis to prognosis.

  2011cites this paper
• Elevation of Serum Galectin-3 and Liver Stiffness Measured by Transient Elastography in Biliary Atresia

  2011cites this paper
• Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis.

  2011cites this paper
• High serum matrix metalloproteinase-3 and liver stiffness in postoperative biliary atresia

  2011cites this paper
• comparison to intrahepatic cholestasis

  2011cites this paper
• Biochemical alterations in malignant obstructive jaundice: Effect of pre-operative drainage

  2010cites this paper
• Cyclooxygenase-2 overexpression is associated with clinical outcome in biliary atresia.

  2010cites this paper
• Serum vascular endothelial growth factor per platelet count in patients with biliary atresia

  2010cites this paper
• Correlation of Circulating Endoglin with Clinical Outcome in Biliary Atresia

  2010cites this paper
• Cyclooxygenase-2 Overexpression is Associated with Clinical Outcome in Biliary Atresia

  2010cites this paper
• Cholangiocyte secretion of chemokines in experimental biliary atresia.

  2009cites this paper
• Elevated Serum Bone Morphogenetic Protein 7 Levels and Clinical Outcome in Children with Biliary Atresia

  2009cites this paper
• Elevated serum macrophage migration inhibitory factor levels in post-operative biliary atresia.

  2009cites this paper
• High levels of serum basic fibroblast growth factor in children with biliary atresia.

  2008cites this paper
• Elevated Serum Soluble E-Selectin is Associated with Poor Outcome and Correlated with Serum ALT in Biliary Atresia

  2008cites this paper
• Overexpression of hepatic inducible nitric oxide synthase in biliary atresia

  2008cites this paper
• Serum Transforming Growth Factor-β1 and Epidermal Growth Factor in Biliary Atresia

  2008cites this paper
• Serial circulating markers of inflammation in biliary atresia—Evolution of the post‐operative inflammatory process

  2007cites this paper
• Analysis of connective tissue growth factor promoter polymorphism in Thai children with biliary atresia.

  2007cites this paper
• Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia

  2007cites this paper
• High-dose steroids do not improve early outcome in biliary atresia.

  2007cites this paper
• Cytokines in Human Colostrum and Neonatal Jaundice

  2007cites this paper
• Elevation of serum stem‐cell factor in postoperative biliary atresia

  2007cites this paper
• Implication of innate immunity in the pathogenesis of biliary atresia.

  2006cites this paper
• Association of serum levels of tissue inhibitors of metalloproteinase-1 with clinical outcome in children with biliary atresia.

  2006cites this paper
• The role of monocyte chemoattractant protein-1 in biliary atresia.

  2006cites this paper